There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To assess the safety of adalimumab in global clinical trials and postmarketing surveillance
among patients with rheumatoid arthritis (RA).
[1
]
Clinical Research, Denver Arthritis Clinic, 200 Spruce Street, Suite 100, Denver,
CO 80230, USA, and Department of Rheumatology, Charité Humboldt University, Berlin,
Germany. crendon@denverarthritisclinic.com